Virology. Epstein-Barr virus turns 50.
作者信息
Lieberman Paul M
机构信息
The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104-4265, USA.
出版信息
Science. 2014 Mar 21;343(6177):1323-5. doi: 10.1126/science.1252786.
Abstract
摘要
相似文献
1
Virology. Epstein-Barr virus turns 50.
Science. 2014 Mar 21;343(6177):1323-5. doi: 10.1126/science.1252786.
2
[Epstein-Barr virus].
Nihon Rinsho. 2003 Mar;61 Suppl 3:582-6.
3
The Role of the Epstein-Barr virus in human disease.
Front Biosci. 2002 Feb 1;7:d519-40. doi: 10.2741/murray.
4
Reactivation of Epstein-Barr virus from latency.
Rev Med Virol. 2005 May-Jun;15(3):149-56. doi: 10.1002/rmv.456.
5
Epstein-Barr virus: the path from association to causality for a ubiquitous human pathogen.
PLoS Biol. 2014 Sep 2;12(9):e1001939. doi: 10.1371/journal.pbio.1001939. eCollection 2014 Sep.
6
A new animal model for Epstein-Barr virus pathogenesis.
Curr Top Microbiol Immunol. 2001;258:201-19. doi: 10.1007/978-3-642-56515-1_13.
7
The ecology and pathology of Epstein-Barr virus.
Immunol Cell Biol. 1995 Dec;73(6):489-504. doi: 10.1038/icb.1995.79.
8
Vaccine Development for Epstein-Barr Virus.
Adv Exp Med Biol. 2018;1045:477-493. doi: 10.1007/978-981-10-7230-7_22.
9
[Immunologic tests: Epstein-Barr virus].
Nihon Rinsho. 2005 Jul;63 Suppl 7:300-3.
10
Epstein-Barr virus (EBV) associated lesions of the head and neck.
Oral Dis. 1996 Jun;2(2):117-24. doi: 10.1111/j.1601-0825.1996.tb00211.x.
引用本文的文献
1
EBV-Derived miR-BART20-3p Influences Proliferation and Migration in EBV-Positive Gastric Cancer Models by Suppressing PPARα.
Microorganisms. 2025 Jun 28;13(7):1514. doi: 10.3390/microorganisms13071514.
2
EBNA leader protein orchestrates chromatin architecture remodeling during Epstein-Barr virus-induced B cell transformation.
Nucleic Acids Res. 2025 Jun 20;53(12). doi: 10.1093/nar/gkaf629.
3
Epstein-Barr Virus-Driven B-Cell Transformation under Germinal Center Hypoxia Requires External Unsaturated Fatty Acids.
Res Sq. 2025 Apr 24:rs.3.rs-6506954. doi: 10.21203/rs.3.rs-6506954/v1.
4
Animal models of human herpesvirus infection.
Animal Model Exp Med. 2025 Apr;8(4):615-628. doi: 10.1002/ame2.12575. Epub 2025 Feb 7.
5
Epstein-Barr virus-driven cardiolipin synthesis sustains metabolic remodeling during B cell transformation.
Sci Adv. 2025 Jan 31;11(5):eadr8837. doi: 10.1126/sciadv.adr8837. Epub 2025 Jan 29.
6
Immune Modulation by Epstein-Barr Virus Lytic Cycle: Relevance and Implication in Oncogenesis.
Pathogens. 2024 Oct 8;13(10):876. doi: 10.3390/pathogens13100876.
7
Prospective evaluation of the relevance of Epstein-Barr virus antibodies for early detection of nasopharyngeal carcinoma in Chinese adults.
Int J Epidemiol. 2024 Jun 12;53(4). doi: 10.1093/ije/dyae098.
8
Epstein-Barr-Virus-Driven Cardiolipin Synthesis Sustains Metabolic Remodeling During B-cell Lymphomagenesis.
Res Sq. 2024 Apr 8:rs.3.rs-4013392. doi: 10.21203/rs.3.rs-4013392/v1.
9
Viral remodeling of the 4D nucleome.
Exp Mol Med. 2024 Apr;56(4):799-808. doi: 10.1038/s12276-024-01207-0. Epub 2024 Apr 25.
10
RNA-Seq and miRNA-Seq data from Epstein-Barr virus-infected tree shrews reveal a ceRNA network contributing to immune microenvironment regulation.
Virulence. 2024 Dec;15(1):2306795. doi: 10.1080/21505594.2024.2306795. Epub 2024 Jan 29.
本文引用的文献
1
Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas.
Cell Rep. 2013 Oct 31;5(2):458-70. doi: 10.1016/j.celrep.2013.09.012. Epub 2013 Oct 10.
2
Addressing the growing international challenge of cancer: a multinational perspective.
Sci Transl Med. 2013 Mar 6;5(175):175cm2. doi: 10.1126/scitranslmed.3005899.
3
Novel mechanisms of EBV-induced oncogenesis.
Curr Opin Virol. 2012 Aug;2(4):453-8. doi: 10.1016/j.coviro.2012.07.001. Epub 2012 Aug 1.
4
T-cell therapy in the treatment of post-transplant lymphoproliferative disease.
Nat Rev Clin Oncol. 2012 Sep;9(9):510-9. doi: 10.1038/nrclinonc.2012.111. Epub 2012 Jul 17.
5
Epstein-Barr virus: an important vaccine target for cancer prevention.
Sci Transl Med. 2011 Nov 2;3(107):107fs7. doi: 10.1126/scitranslmed.3002878.
6
Autoimmune disease: A role for new anti-viral therapies?
Autoimmun Rev. 2011 Dec;11(2):88-97. doi: 10.1016/j.autrev.2011.08.005. Epub 2011 Aug 18.
7
The curious case of the tumour virus: 50 years of Burkitt's lymphoma.
Nat Rev Microbiol. 2008 Dec;6(12):913-24. doi: 10.1038/nrmicro2015.
8
Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults.
J Infect Dis. 2007 Dec 15;196(12):1749-53. doi: 10.1086/523813.
9
The global health burden of infection-associated cancers in the year 2002.
Int J Cancer. 2006 Jun 15;118(12):3030-44. doi: 10.1002/ijc.21731.
10
Epstein-Barr virus: 40 years on.
Nat Rev Cancer. 2004 Oct;4(10):757-68. doi: 10.1038/nrc1452.
Zotero 插件